Comparative Pharmacology
Head-to-head clinical analysis: DEXTROSE 5 AND ELECTROLYTE NO 48 IN PLASTIC CONTAINER versus DEXTROSE 5 AND POTASSIUM CHLORIDE 0 3 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DEXTROSE 5 AND ELECTROLYTE NO 48 IN PLASTIC CONTAINER versus DEXTROSE 5 AND POTASSIUM CHLORIDE 0 3 IN PLASTIC CONTAINER.
DEXTROSE 5% AND ELECTROLYTE NO. 48 IN PLASTIC CONTAINER vs DEXTROSE 5% AND POTASSIUM CHLORIDE 0.3% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dextrose provides caloric support and restores blood glucose levels, while electrolytes (such as sodium, potassium, magnesium, chloride, acetate, and phosphate) replace deficits and maintain acid-base balance. The specific electrolyte composition in No. 48 (e.g., sodium, potassium, magnesium, chloride, acetate, phosphate) aids in rehydration and correction of electrolyte disturbances.
Dextrose provides a source of calories and energy by entering the glycolytic pathway and being metabolized to carbon dioxide and water. Potassium chloride replenishes potassium ions, which are essential for nerve impulse conduction, muscle contraction, and maintaining intracellular osmotic pressure.
Intravenous administration; dosing is based on fluid and electrolyte requirements, typically 1-2 L per 24 hours for adults, infused at a rate of 100-200 mL/hour, adjusted according to clinical status and serum electrolyte levels.
Intravenous infusion of potassium chloride 0.3% in dextrose 5% at a rate determined by potassium deficit and patient tolerance, typically 10-20 mEq per hour; maximum infusion rate 40 mEq/hour in non-emergency situations.
None Documented
None Documented
Dextrose: terminal elimination half-life is approximately 2-3 hours in non-diabetic individuals, reflecting glucose utilization and storage; prolonged in renal impairment due to decreased clearance of metabolites. Electrolytes: half-life varies; sodium and chloride have elimination half-lives of 6-12 hours; potassium half-life is 12-24 hours; magnesium half-life is 24-48 hours; acetate half-life is minutes (rapid metabolism).
Not applicable as a single drug; potassium's terminal half-life ~12-24 hours (depends on total body stores and renal function); dextrose half-life ~15-20 minutes (highly variable with insulin response). Clinical context: half-life relevant only for potassium monitoring in renal impairment.
Dextrose is completely metabolized to carbon dioxide and water in the presence of insulin; minimal renal excretion (<5%) as unchanged glucose in normoglycemic individuals. Electrolytes (sodium, chloride, potassium, magnesium, acetate, gluconate) are primarily excreted renally; renal elimination accounts for >90% of sodium and chloride, ~80% of potassium, and ~70% of magnesium. Acetate is rapidly metabolized to bicarbonate. Gluconate is partially excreted renally and partially metabolized.
Potassium: >90% renal excretion. Dextrose: metabolized to CO2 and water; no significant renal excretion of intact glucose unless hyperglycemia exceeds renal threshold.
Category C
Category C
IV Fluid
IV Fluid